scholarly journals Validation of the Infectious Disease Society of America/American Thoracic Society 2007 guidelines for severe community-acquired pneumonia*

2009 ◽  
Vol 37 (12) ◽  
pp. 3010-3016 ◽  
Author(s):  
Samuel M. Brown ◽  
Barbara E. Jones ◽  
Al R. Jephson ◽  
Nathan C. Dean
Keyword(s):  
Infectious Disease ◽  
Community Acquired Pneumonia ◽  
American Thoracic Society ◽  
Infectious Disease Society ◽  
Severe Community Acquired Pneumonia

scholarly journals Clinical Guideline Highlights for the Hospitalist: 2019 American Thoracic Society/Infectious Disease Society of America Update on Community-Acquired Pneumonia

2020 ◽  
Vol 15 (12) ◽  
pp. 743-745
Author(s):  
Christopher D Jackson ◽  
Desiree C Burroughs-Ray ◽  
Nathan A Summers
Keyword(s):  
Infectious Disease ◽  
Infectious Diseases ◽  
Clinical Guideline ◽  
Target Population ◽  
Community Acquired Pneumonia ◽  
American Thoracic Society ◽  
Funding Source ◽  
Consensus Guidelines ◽  
Release Date ◽  
Immunocompetent Adult

GUIDELINE TITLE: Diagnosis and Treatment of Adults with Community Acquired Pneumonia: An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America RELEASE DATE: October 2019 PRIOR VERSION: 2007 Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults DEVELOPER: American Thoracic Society and Infectious Diseases Society of America FUNDING SOURCE: American Thoracic Society and Infectious Diseases Society of America TARGET POPULATION: Immunocompetent adult patients with community-acquired pneumonia

scholarly journals Corticosteroids for CAP, influenza and COVID-19: when, how and benefits or harm?

2021 ◽  
Vol 30 (159) ◽  
pp. 200346
Author(s):  
Ignacio Martin-Loeches ◽  
Antoni Torres
Keyword(s):  
Infectious Disease ◽  
Septic Shock ◽  
Nosocomial Infection ◽  
Supportive Care ◽  
Community Acquired Pneumonia ◽  
American Thoracic Society ◽  
New Antibiotics ◽  
Long Time ◽  
Potential Alternative

PurposeCorticosteroids have been considered in medicine for a long time, and they are broadly prescribed. In infectious diseases, corticosteroids have been regarded as a thread due to their immunosuppressive effects and therefore their anti-inflammatory properties.MainIn recent years, there have been several studies published that aimed to determine the role of corticosteroids in patients with community-acquired pneumonia (CAP), because, despite significant advances in new antibiotics and supportive care, deaths of patients with CAP remain unacceptably high. While the 2007 Infectious Disease Society of America (IDSA)/American Thoracic Society (ATS) CAP guidelines did not mention the use of corticosteroids in the management of CAP, the recently published 2019 IDSA/ATS guidelines recommended their use in patients with septic shock refractory to vasopressors and fluid resuscitation. Regarding viral infection, the use of corticosteroids in patients with influenza has shown to be associated with significantly higher mortality and higher incidence of nosocomial infection, while in patients with coronavirus disease 2019 (COVID-19) there is a good body of evidence of the benefit of corticosteroids in terms of mortality.ConclusionsThe use of corticosteroids has been considered as a potential alternative co-adjuvant treatment in patients with pneumonia. In patients with COVID-19, the evidence is quite strong and there is a clear benefit of the use of corticosteroids in those patients presenting severe forms of disease.

Sign in / Sign up

Export Citation Format

Share Document